Answers are grounded in this paper and cite their sources.
These findings establish the effectiveness of niosomes as inhalable delivery carriers which could serve as a promising strategy for delivery of nintedanib to treat several lung cancers.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: